Common pathway signature in lung and liver fibrosis

References

• Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011; 6:425-56; PMID:21073339; http://dx.doi.org/10.1146/annurev-pathol-011110-130246
   PubMed Web of Science ®Google Scholar
• Mehal WZ, Iredale J, Friedman SL. Scraping fibrosis: expressway to the core of fibrosis. Nat Med 2011; 17:552-3; PMID:21546973; http://dx.doi.org/10.1038/nm0511-552
   PubMed Web of Science ®Google Scholar
• Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174:810-6; PMID:16809633; http://dx.doi.org/10.1164/rccm.200602-163OC
   PubMed Web of Science ®Google Scholar
• Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005; 50:171-80; PMID:15712657; http://dx.doi.org/10.1007/s10620-005-1267-z
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Kalluri R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol 2013; 304:C216-25; PMID:23255577; http://dx.doi.org/10.1152/ajpcell.00328.2012
   PubMed Web of Science ®Google Scholar
• Eddy AA. Scraping fibrosis: UMODulating renal fibrosis. Nat Med 2011; 17:553-5; PMID:21546974; http://dx.doi.org/10.1038/nm0511-553
   PubMed Web of Science ®Google Scholar
• Yu Z, Xie M, Fan X, Jia J. Interferon alpha2b Increases MMP-13 and IL-10 expression in Kupffer cells through MAPK signaling pathways. Hepatogastroenterology 2015; 62:350-4; PMID:25993756.
   PubMed Web of Science ®Google Scholar
• Nanthakumar CB, Hatley RJ, Lemma S, Gauldie J, Marshall RP, Macdonald SJ. Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nat Rev Drug Discov 2015; 14:693-720; PMID:26338155; http://dx.doi.org/10.1038/nrd4592
   PubMed Web of Science ®Google Scholar
• Rockey DC, Bell PD, Hill JA. Fibrosis–a common pathway to organ injury and failure. N Engl J Med 2015; 372:1138-49; PMID:25785971; http://dx.doi.org/10.1056/NEJMra1300575
   PubMed Web of Science ®Google Scholar
• Buzdin AA, Zhavoronkov AA, Korzinkin MB, Venkova LS, Zenin AA, Smirnov PY, Borisov NM. Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data. Front Genet 2014; 5:55; PMID:24723936; http://dx.doi.org/10.3389/fgene.2014.00055
   PubMed Web of Science ®Google Scholar
• Buzdin AA, Zhavoronkov AA, Korzinkin MB, Roumiantsev SA, Aliper AM, Venkova LS, Smirnov PY, Borisov NM. The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis. Front Mol Biosci 2014; 1:8; PMID:25988149; http://dx.doi.org/10.3389/fmolb.2014.00008
   PubMedGoogle Scholar
• Zhu Q, Izumchenko E, Aliper AM, Makarev E, Paz K, Buzdin AA, Zhavoronkov AA, Sidransky D. Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients. Human Genome Variation 2015; 2; http://dx.doi.org/10.1038/hgv.2015.9
   PubMedGoogle Scholar
• Madala SK, Schmidt S, Davidson C, Ikegami M, Wert S, Hardie WD. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol 2012; 46:380-8; PMID:22021337; http://dx.doi.org/10.1165/rcmb.2011-0237OC
   PubMed Web of Science ®Google Scholar
• Sebe A, Masszi A, Zulys M, Yeung T, Speight P, Rotstein OD, Nakano H, Mucsi I, Szaszi K, Kapus A. Rac, PAK and p38 regulate cell contact-dependent nuclear translocation of myocardin-related transcription factor. FEBS Lett 2008; 582:291-8; PMID:18154735; http://dx.doi.org/10.1016/j.febslet.2007.12.021
   PubMed Web of Science ®Google Scholar
• Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, Fagan P, Baccei CS, Santini AM, Hutchinson JH, et al. A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol 2010; 160:1699-713; PMID:20649573; http://dx.doi.org/10.1111/j.1476-5381.2010.00828.x
   PubMed Web of Science ®Google Scholar
• Pyne NJ, Dubois G, Pyne S. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis. Biochim Biophys Acta 2013; 1831:228-38; PMID:22801038; http://dx.doi.org/10.1016/j.bbalip.2012.07.003
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425:577-84; PMID:14534577; http://dx.doi.org/10.1038/nature02006
   PubMed Web of Science ®Google Scholar
• Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002; 7:d793-807; PMID:11897555; http://dx.doi.org/10.2741/gressner
   PubMed Web of Science ®Google Scholar
• Nishida M, Okumura Y, Sato H, Hamaoka K. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy. Nephrol Dial Transplant 2008; 23:2520-4; PMID:18515792; http://dx.doi.org/10.1093/ndt/gfn309
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ikegami T, Honda A, Miyazaki T, Bouscarel B, Rojkind M, Hyodo I, Matsuzaki Y. Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology 2006; 44:612-22; PMID:16941698; http://dx.doi.org/10.1002/hep.21315
   PubMed Web of Science ®Google Scholar
• Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, Williams AS, Lambie M, Foster TL, Liao CT, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 2014; 40:40-50; PMID:24412616; http://dx.doi.org/10.1016/j.immuni.2013.10.022
   PubMed Web of Science ®Google Scholar
• Kong X, Horiguchi N, Mori M, Gao B. Cytokines and STATs in Liver Fibrosis. Front Physiol 2012; 3:69; PMID:22493582; http://dx.doi.org/10.3389/fphys.2012.00069
   PubMed Web of Science ®Google Scholar
• Vallath S, Hynds RE, Succony L, Janes SM, Giangreco A. Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities. Eur Respir J 2014; 44:513-22; PMID:24435005; http://dx.doi.org/10.1183/09031936.00146413
   PubMed Web of Science ®Google Scholar
• Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, Lauwers GY, McGinn CM, DePeralta DK, Chen X, Kuroda T, et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 2014; 59:1577-90; PMID:24677197; http://dx.doi.org/10.1002/hep.26898
   PubMed Web of Science ®Google Scholar
• Johnson A, DiPietro LA. Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J 2013; 27:3893-901; PMID:23783074; http://dx.doi.org/10.1096/fj.12-214189
   PubMed Web of Science ®Google Scholar
• Koike K, Ueda S, Yamagishi S, Yasukawa H, Kaida Y, Yokoro M, Fukami K, Yoshimura A, Okuda S. Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstruction. Clin Immunol 2014; 150:78-87; PMID:24333535; http://dx.doi.org/10.1016/j.clim.2013.11.003
   PubMed Web of Science ®Google Scholar
• Serrano I, McDonald PC, Lock FE, Dedhar S. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFbeta-1-induced epithelial-mesenchymal transition (EMT). Oncogene 2013; 32:50-60; PMID:22310280; http://dx.doi.org/10.1038/onc.2012.30
   PubMed Web of Science ®Google Scholar
• Deng YL, Xiong XZ, Cheng NS. Organ fibrosis inhibited by blocking transforming growth factor-beta signaling via peroxisome proliferator-activated receptor gamma agonists. Hepatobiliary Pancreat Dis Int 2012; 11:467-78; PMID:23060391; http://dx.doi.org/10.1016/S1499-3872(12)60210-0
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res 2009; 19:128-39; PMID:19114990; http://dx.doi.org/10.1038/cr.2008.328
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18:816-27; PMID:15117886; http://dx.doi.org/10.1096/fj.03-1273rev
   PubMed Web of Science ®Google Scholar
• Hanna C, Hubchak SC, Liang X, Rozen-Zvi B, Schumacker PT, Hayashida T, Schnaper HW. Hypoxia-inducible factor-2alpha and TGF-beta signaling interact to promote normoxic glomerular fibrogenesis. Am J Physiol Renal Physiol 2013; 305:F1323-31; PMID:23946285; http://dx.doi.org/10.1152/ajprenal.00155.2013
   PubMedGoogle Scholar
• Pohlers D, Brenmoehl J, Loffler I, Muller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta 2009; 1792:746-56; PMID:19539753; http://dx.doi.org/10.1016/j.bbadis.2009.06.004
   PubMed Web of Science ®Google Scholar
• Mallat A, Lotersztajn S. The liver X receptor in hepatic stellate cells: a novel antifibrogenic target? J Hepatol 2011; 55:1452-4; PMID:21782759; http://dx.doi.org/10.1016/j.jhep.2011.05.018
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu J, Zheng Y, Chen W, Sun Y, Wu Z, Luo M. Effect of the regulation of retinoid X receptor-alpha gene expression on rat hepatic fibrosis. Hepatol Res 2011; 41:475-83; PMID:21518404; http://dx.doi.org/10.1111/j.1872-034X.2011.00794.x
   PubMed Web of Science ®Google Scholar
• Pan LH, Ohtani H, Yamauchi K, Nagura H. Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 1996; 46:91-9; PMID:10846556; http://dx.doi.org/10.1111/j.1440-1827.1996.tb03584.x
   PubMed Web of Science ®Google Scholar
• Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 2009; 296:G1324-31; PMID:19342509; http://dx.doi.org/10.1152/ajpgi.90564.2008
   PubMed Web of Science ®Google Scholar
• Sziksz E, Pap D, Lippai R, Beres NJ, Fekete A, Szabo AJ, Vannay A. Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family. Mediators Inflamm 2015; 2015:764641; PMID:26199463; http://dx.doi.org/10.1155/2015/764641
   PubMed Web of Science ®Google Scholar
• Sun L, Louie MC, Vannella KM, Wilke CA, LeVine AM, Moore BB, Shanley TP. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol 2011; 300:L341-53; PMID:21131395; http://dx.doi.org/10.1152/ajplung.00122.2010
   PubMed Web of Science ®Google Scholar
• Fernandez IE, Eickelberg O. The impact of TGF-beta on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 2012; 9:111-6; PMID:22802283; http://dx.doi.org/10.1513/pats.201203-023AW
   PubMedGoogle Scholar
• Morrisey EE. Wnt signaling and pulmonary fibrosis. Am J Pathol 2003; 162:1393-7; PMID:12707021; http://dx.doi.org/10.1016/S0002-9440(10)64271-X
   PubMed Web of Science ®Google Scholar
• Miao CG, Yang YY, He X, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J. Wnt signaling in liver fibrosis: progress, challenges and potential directions. Biochimie 2013; 95:2326-35; PMID:24036368; http://dx.doi.org/10.1016/j.biochi.2013.09.003
   PubMed Web of Science ®Google Scholar
• Wells RG. The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow? Hepatology 2010; 51:737-40; PMID:20198628.
   PubMed Web of Science ®Google Scholar
• Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 2011; 73:413-35; PMID:21054168; http://dx.doi.org/10.1146/annurev-physiol-012110-142225
   PubMed Web of Science ®Google Scholar
• Borisov NM, Terekhanova NV, Aliper AM, Venkova LS, Smirnov PY, Roumiantsev S, Korzinkin MB, Zhavoronkov AA, Buzdin AA. Signaling pathways activation profiles make better markers of cancer than expression of individual genes. Oncotarget 2014; 5:10198-205; PMID:25415353; http://dx.doi.org/10.18632/oncotarget.2548
   PubMed Web of Science ®Google Scholar
• Le TT, Karmouty-Quintana H, Melicoff E, Le TT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, et al. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis. J Immunol 2014; 193:3755-68; PMID:25172494; http://dx.doi.org/10.4049/jimmunol.1302470
   PubMed Web of Science ®Google Scholar
• O'Reilly S, Ciechomska M, Cant R, van Laar JM. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem 2014; 289:9952-60; PMID:24550394; http://dx.doi.org/10.1074/jbc.M113.545822
   PubMed Web of Science ®Google Scholar
• Kavvadas P, Kypreou KP, Protopapadakis E, Prodromidi E, Sideras P, Charonis AS. Integrin-linked kinase (ILK) in pulmonary fibrosis. Virchows Arch 2010; 457:563-75; PMID:20857141; http://dx.doi.org/10.1007/s00428-010-0976-7
   PubMed Web of Science ®Google Scholar
• Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol 2012; 8:e1002375; PMID:22383865; http://dx.doi.org/10.1371/journal.pcbi.1002375
   PubMed Web of Science ®Google Scholar
• Jin L, Zuo XY, Su WY, Zhao XL, Yuan MQ, Han LZ, Zhao X, Chen YD, Rao SQ. Pathway-based analysis tools for complex diseases: a review. Genomics Proteomics Bioinformatics 2014; 12:210-20; PMID:25462153; http://dx.doi.org/10.1016/j.gpb.2014.10.002
   PubMedGoogle Scholar
• Venkova L, Aliper A, Suntsova M, Kholodenko R, Shepelin D, Borisov N, Malakhova G, Vasilov R, Roumiantsev S, Zhavoronkov A, et al. Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs. Oncotarget 2015; 6:27227-38; PMID:26317900; http://dx.doi.org/10.18632/oncotarget.4507
   PubMed Web of Science ®Google Scholar
• Artemov A, Aliper A, Korzinkin M, Lezhnina K, Jellen L, Zhukov N, Roumiantsev S, Gaifullin N, Zhavoronkov A, Borisov N, et al. A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation. Oncotarget 2015; 6:29347-56; PMID:26320181.
   PubMed Web of Science ®Google Scholar
• Lezhnina K, Kovalchuk O, Zhavoronkov AA, Korzinkin MB, Zabolotneva AA, Shegay PV, Sokov DG, Gaifullin NM, Rusakov IG, Aliper AM, et al. Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways. Oncotarget 2014; 5:9022-32; PMID:25296972; http://dx.doi.org/10.18632/oncotarget.2493
   PubMed Web of Science ®Google Scholar
• Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, Liu F, Ifedigbo E, Xu X, Oury TD, Kaminski N, et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 2006; 203:2895-906; PMID:17178917; http://dx.doi.org/10.1084/jem.20061536
   PubMed Web of Science ®Google Scholar
• Moylan CA, Pang H, Dellinger A, Suzuki A, Garrett ME, Guy CD, Murphy SK, Ashley-Koch AE, Choi SS, Michelotti GA, et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 2014; 59:471-82; PMID:23913408; http://dx.doi.org/10.1002/hep.26661
   PubMed Web of Science ®Google Scholar